Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarun Garg

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Drug Delivery|May 30, 2014
Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugsRanjot Kaur, Tarun Garg, Basant Malik, et al.
Surgical Neurology International|May 8, 2023
A prospective study to determine the risk factors associated with post traumatic seizures: A single institution experienceTarun Garg, Raghav Sood, Akshay Chaudhary, et al.
Oncotarget|June 21, 2014
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisXenofon Papanikolaou, Sarah Johnson, Tarun Garg, et al.
Cytotherapy|December 22, 2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103Amberly Moreno-Bost, Susann Szmania, Katie Stone, et al.
Tissue Engineering|February 3, 2005
Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transductionNalini Agrawal, Hong You, Yong Liu, et al.
Frontiers in Immunology|April 4, 2025
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patientsAllan Feng, Michael V Gonzalez, Muge Kalaycioglu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.
Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Drug Delivery|May 30, 2014
Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugsRanjot Kaur, Tarun Garg, Basant Malik, et al.
Surgical Neurology International|May 8, 2023
A prospective study to determine the risk factors associated with post traumatic seizures: A single institution experienceTarun Garg, Raghav Sood, Akshay Chaudhary, et al.
Oncotarget|June 21, 2014
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisXenofon Papanikolaou, Sarah Johnson, Tarun Garg, et al.
Cytotherapy|December 22, 2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103Amberly Moreno-Bost, Susann Szmania, Katie Stone, et al.
Tissue Engineering|February 3, 2005
Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transductionNalini Agrawal, Hong You, Yong Liu, et al.
Frontiers in Immunology|April 4, 2025
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patientsAllan Feng, Michael V Gonzalez, Muge Kalaycioglu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.
Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.
Pageof 8